P.J. Schmidt Investment Management (PJS)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-36,634
Closed -$993K 133
2016
Q1
$993K Sell
36,634
-1,426
-4% -$38.2K 0.39% 71
2015
Q4
$1.1M Sell
38,060
-10
-0% -$277 0.44% 67
2015
Q3
$1.03M Sell
38,070
-210
-0.5% -$5.95K 0.45% 67
2015
Q2
$1.05M Buy
38,280
+180
+0.5% +$5.06K 0.41% 72
2015
Q1
$1.02M Sell
38,100
-40
-0.1% -$921 0.4% 77
2014
Q4
$807K Sell
38,140
-490
-1% -$10.9K 0.32% 84
2014
Q3
$920K Buy
38,630
+1,020
+3% +$23.5K 0.38% 71
2014
Q2
$869K Buy
37,610
+7,690
+26% +$170K 0.34% 76
2014
Q1
$683K Sell
29,920
-4,300
-13% -$91.6K 0.27% 92
2013
Q4
$632K Sell
34,220
-1,000
-3% -$17.4K 0.27% 83
2013
Q3
$596K Buy
35,220
+800
+2% +$13.5K 0.27% 78
2013
Q2
$533K Buy
+34,420
New +$573K 0.26% 75

Other funds holding NVO

P.J. Schmidt Investment Management (PJS)'s NVO Position: Q2 2016 in Review

P.J. Schmidt Investment Management (PJS) sold out of Novo Nordisk (NVO) in Q2 2016, closing a stake of 36,634 shares — an estimated $993K sold.

P.J. Schmidt Investment Management (PJS) first reported a position in NVO in Q2 2013 and held it in 12 quarters. The position peaked at $1.1M in Q4 2015. 529 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

  • P.J. Schmidt Investment Management (PJS) reported no remaining Novo Nordisk position as of Q2 2016 after selling out during the quarter.
  • P.J. Schmidt Investment Management (PJS) sold 36,634 Novo Nordisk shares in Q2 2016, an estimated $993K.
  • P.J. Schmidt Investment Management (PJS) first reported a position in Novo Nordisk in Q2 2013 and held it in 12 quarters.
  • P.J. Schmidt Investment Management (PJS)'s Novo Nordisk position peaked at $1.1M in Q4 2015.
  • 529 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q2 2016, filed 9 Aug 2016.